FDA’s ODAC Says Lilly & Innovent Must Run U.S. Trial
It is not uncommon for different countries to require at least part of a clinical trial be conducted in their country. The…
It is not uncommon for different countries to require at least part of a clinical trial be conducted in their country. The…
Summary – – Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b…
Synopsis: In June, globe-trotting contract manufacturer Fujifilm Diosynth Biotechnologies unveiled an $850 million outlay to boost biologics capacity in the U.S. and…
Italian drugmaker Recordati has agreed on a price for six-year-old EUSA Pharma. The Milan-based firm will pay €750m ($845 million) for EUSA’s…